OOIR: Observatory of International Research

Papers

(The TQCC of Pituitary is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Idiopathic central diabetes insipidus in a large cohort of patients: the hypopituitarism ENEA rare observational (HEROS) study	102
Predictors of biochemical remission after transsphenoidal surgery in a large cohort of acromegaly patients	46
Substance P and Neurokinin-1 receptor are overexpressed in adamantinomatous craniopharyngioma than in the pituitary gland	41
Neuromedin B receptor as a potential therapeutic target for corticotroph adenomas	34
The impact of facility type and volume on treatment and overall survival in craniopharyngioma	32
Prevalence and risk factors of colon polyps and other colonic lesions in acromegaly: Insights from colonoscopy screening	30
Development of a cost-effective diagnostic algorithm incorporating transcription factor immunohistochemistry in the evaluation of pituitary tumours	30
Correction to: Osilodrostat improves blood pressure and glycemic control in patients with Cushing’s disease: a pooled analysis of LINC 3 and LINC 4 studies	29
A comparison of macular ganglion cell and retinal nerve fibre layer optical coherence tomographic parameters as predictors of visual outcomes of surgery for pituitary tumours	26
Weekly somapacitan had no adverse effects on glucose metabolism in adults with growth hormone deficiency	26
Semaglutide treatment in hypothalamic obesity: Two-Year outcomes on body composition, appetite, and quality of life	25
Pituitary: hic manebimus optime	24
The assessment of thiol-disulfide homeostasis and ıschemia-modified albumin levels in patients with acromegaly	24
Genetic models of Cushing’s disease	23
Discrimination between non-functioning pituitary adenomas and hypophysitis using machine learning methods based on magnetic resonance imaging‑derived texture features	22
Basal cortisol in relation to metyrapone confirmation in predicting adrenal insufficiency after pituitary surgery	21
Acromegaly increases depressive symptoms and reduces quality of life of cohabitants	21
Pituitary metastases: a case series and scoping review	21
Radiological evolution of autograft fat used for skull base reconstruction after transsphenoidal surgery for pituitary adenomas	21
Sleep disruption in patients with active and treated endogenous Cushing’s syndrome	20
Machine learning as a clinical decision support tool for patients with acromegaly	19
Hospital frailty risk score predicts postoperative outcomes after endoscopic endonasal resection of non-functioning pituitary adenomas	19
Complications and mortality of Cushing’s disease: report on data collected over a 20-year period at a referral centre	19
Gigantism: microsurgical treatment by transsphenoidal approach and prognostic factors	19
Implementation of functional imaging using 11C-methionine PET-CT co-registered with MRI for advanced surgical planning and decision making in prolactinoma surgery	18

Functioning gonadotroph adenomas in premenopausal women: clinical and molecular characterization and review of the literature	18
ACRODAT and SAGIT for the assessment of disease activity in acromegaly: a multicenter study of the Veneto region in Italy	17
Correction: Development and validation of a novel treatment adherence, satisfaction and knowledge questionnaire (TASK-Q) for adult patients with hypothalamic-pituitary disorders	17
Bone health and skeletal fragility in second- and third-line medical therapies for acromegaly: preliminary results from a pilot single center experience	17
A post-hoc internal validation of arginine-stimulated copeptin cut-offs for diagnosing AVP deficiency (central diabetes insipidus)	16
TSH-secreting pituitary adenomas and bone	16
The diagnosis and prevalence of hypoprolactinemia in patients with panhypopituitarism and the effects on depression and sexual functions	15
IGF-1 is positively associated with BMI in patients with acromegaly	15
Pituitary surgery in Cushing’s disease: first line treatment and role of reoperation	15
How to rule out non-neoplastic hypercortisolemia (previously known as pseudo-cushing)	15
Commentary: The updated European society of endocrinology clinical practice guideline for the management of aggressive pituitary tumors and pituitary carcinomas	15
Cushing’s disease and bone	15
Diagnosis of growth hormone deficiency: searching for Consensus along life	15
Shared decision-making and detection of comorbidities in an online acromegaly consultation with and without the Acromegaly Disease Activity Tool ACRODAT® using the simulated person approach	14
Hypopituitarism and bone disease: pathophysiology, diagnosis and treatment outcomes	14
Predicting tumor consistency and extent of resection in non-functioning pituitary tumors	13
Reappraising prediction of surgical complexity of non-functioning pituitary adenomas after transsphenoidal surgery: the modified TRANSSPHER grade	13
Psychiatric morbidity in acromegaly: a cohort study and meta-analysis of the literature	13
Response to letter to the editor “Hypopituitarism and COVID-19, what else?”	13
Medical management pathways for Cushing’s disease in pituitary tumors centers of excellence (PTCOEs)	13
Generating novel pituitary datasets from open-source imaging data and deep volumetric segmentation	13
Clinical, surgical, and endocrine outcome following treatment of posterior pituitary tumors: a retrospective cohort study	12
Copeptin after pituitary surgery: is it worth measuring?	12
Acromegaly is associated with a distinct oral and gut microbiota	12
Outcomes in surgical management of microprolactinomas: an international multi-institutional series	12
Pituitary surgery and COVID	12
Muscle dysfunction is associated with poor quality of life in long-term controlled patients with acromegaly	12
Is diabetes with acromegaly for life?	12
Glucocorticoid Withdrawal Syndrome following treatment of endogenous Cushing Syndrome	12
Long COVID and pituitary dysfunctions: a bidirectional relationship?	11
Serum biomarkers of colonic polyps in patients with acromegaly: a meta-analysis and systematic review	11
Cabergoline treatment for surgery-naïve non-functioning pituitary macroadenomas	11
[68 Ga]-DOTATATE PET/MR-based evaluation of physiologic somatostatin receptor 2 expression in the adult pituitary gland as a function of age and sex in a prospective cohort	11
Clinical and prognostic implications of pituitary macroadenomas (PitNets) grading: a monocentric experience	11
The effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and macimorelin stimulation in healthy adults	10
Determinants of skeletal fragility in acromegaly: a systematic review and meta-analysis	10
Demonstration of the inferior intercavernous sinus is closely linked to the extent of pneumatization of the sphenoid sinus: useful information for the pituitary surgeon	10
Growth hormone insensitivity and adipose tissue: tissue morphology and transcriptome analyses in pigs and humans	10
Skeletal fragility in pituitary disease: how can we predict fracture risk?	10
Headache in patients with non-functioning pituitary adenoma before and after transsphenoidal surgery – a prospective study	10
Refractory nonfunctioning pituitary adenomas	10
Clinical and prognostic significance of granulation patterns in somatotroph adenomas/tumors of the pituitary: a meta-analysis	10
Measuring pituitary tumor volume: a comparison of the simplified and non-simplified ellipsoid equation with the 3D planimetric volume assessment	10
Diffusion-weighted imaging does not seem to be a predictor of consistency in pituitary adenomas	10
Low prevalence of neuropathic-like pain symptoms in long-term controlled acromegaly	10
Usefulness of a clinicopathological classification in predicting treatment-related outcomes and multimodal therapeutic approaches in pituitary adenoma patients: retrospective analysis on a Portuguese	10
Hypopituitarism and pregnancy: clinical characteristics, management and pregnancy outcome	10
Effect of antineoplastic drug therapies on carcinoma and aggressive pituitary tumors: a systematic review and meta-analysis	10
Surgical treatment of cystic pituitary adenomas: literature-based definitions and postoperative outcomes	10
Importance of 24 h ambulatory blood pressure monitoring in patients with acromegaly and correlation with cardiac magnetic resonance findings	10

Characterization of a paradoxical post-operative increase in serum cortisol in Cushing disease	10
Prevalence of comorbidities and concomitant medication use in acromegaly: analysis of real-world data from the United States	9
Cushing’s disease: role of preoperative and primary medical therapy	9
High prevalence of morphometric vertebral fractures opportunistically detected on thoracic radiograms in patients with non-functioning pituitary adenoma	9
Posterior hypothalamic involvement on pre-operative MRI predicts hypothalamic obesity in craniopharyngiomas	9
Semaglutide as a promising treatment for hypothalamic obesity: a six-month case series on four females with craniopharyngioma	9
An update on, and genetics of refractory adenomas of childhood	9
TGFBR3L is associated with gonadotropin production in non-functioning gonadotroph pituitary neuroendocrine tumours	9
Changes in pituitary adenoma patient presentation and outcomes during the COVID pandemic at a Pituitary Center of Excellence	9
Outcomes of stereotactic radiosurgery in nelson’s syndrome: a systematic review and Meta-Analysis	9
Proportion and predictors of Hypogonadism Recovery in Men with Macroprolactinomas treated with dopamine agonists	9
The somatotroph pituitary gland function in high-aged multimorbid hospitalized patients with IGF-I deficiency	9
The diagnosis of GH deficiency in adult β-thalassemic patients: are two different stimulation tests necessary to improve specificity?	8
Alert: misinformation that may hurt patients with both adrenal insufficiency and AVP deficiency	8
Idiopathic isolated adrenocorticotropic hormone deficiency: a systematic review of a heterogeneous and underreported disease	8
Long-term metabolic effectiveness and safety of growth hormone replacement therapy in patients with adult growth hormone deficiency: a single-institution study in Japan	8
The comprehensive evaluation of oral and fecal microbiota in patients with acromegaly	8
HLA analysis of immune checkpoint inhibitor-induced and idiopathic isolated ACTH deficiency	8
Giant prolactinomas, a detailed analysis of 196 adult cases	8
Cushing’s syndrome: Guidance on thromboprophylaxis at last	8
Clinical use of [18F]fluoro-ethyl-L-tyrosine PET co-registered with MRI for localizing prolactinoma remnants	8
Can we predict the risk of venous thromboembolism in patients with Cushing’s syndrome: a nationwide cohort analysis	8
Correction: Impulse control disorders in patients with dopamine agonist-treated pituitary adenomas: a cross-sectional multicenter study	8
Correction: consensus on criteria for acromegaly diagnosis and remission	8
Glucose metabolism, gut-brain hormones, and acromegaly treatment: an explorative single centre descriptive analysis	8
Syndrome of inappropriate antidiuresis/hyponatremia in COVID-19	8
How to manage intolerance to dopamine agonist in patients with prolactinoma	8